Adicciones. 2013;25(1):3-6.
Best practice is the best application of available evidence to current activities in the drugs field. The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) created a web-based tool aimed at bridging together scientific evidence and current practices in the drug addiction field. Beyond dissemination of evidence, the scope is to share best practice among the European countries. The synthesis of the evidence is based on the methods of the Cochrane collaboration (the Drugs and Alcohol Group) and the Grade working group. As of February 2013 the portal encompasses four modules on the effectiveness of demand reduction interventions, a collection of European projects on prevention, treatment, harm reduction and social reintegration and an inventory of European Guidelines and Standards including a bank of instruments to evaluate interventions (http://www.emcdda.europa.eu/bestpractice). The summaries of evidence are presented in a plain language format and include brief explanation of the measures of effect supporting the evidence, but do not provide specific recommendations. The main future challenge of EMCDDA's best practice promotion is to become a service for those willing to implement best practice. The Best Practice Portal should become a platform where to find all is needed for successful implementation (handbooks, training materials, guidelines for evaluation and contacts for mentoring).
最佳实践是将现有证据应用于毒品领域当前活动的最佳方式。欧洲毒品和毒瘾监测中心(EMCDDA)创建了一个基于网络的工具,旨在将毒品成瘾领域的科学证据和当前实践联系起来。除了传播证据外,其目标还在于在欧洲国家之间分享最佳实践。证据的综合是基于 Cochrane 合作组织(毒品和酒精组)和 Grade 工作组的方法。截至 2013 年 2 月,该门户包括四个关于减少需求干预措施效果的模块,一个关于预防、治疗、减少伤害和社会重新融入的欧洲项目集合,以及一个包括评估干预措施的工具库的欧洲准则和标准清单(http://www.emcdda.europa.eu/bestpractice)。证据摘要以通俗易懂的格式呈现,包括支持证据的效果衡量标准的简要说明,但不提供具体建议。EMCDDA 最佳实践推广的主要未来挑战是成为那些愿意实施最佳实践的人的服务。最佳实践门户应该成为一个平台,可以在其中找到成功实施所需的一切(手册、培训材料、评估指南和指导联系)。